Clinical Trial

VividWhite Glaucoma Implant (VW-51) Pivotal Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The VividWhite Glaucoma Implant (VW-51) is a novel surgical implant designed to treat glaucoma. This study is a 12-month, 65-participant non-comparative multicentre study to assess the safety and effectiveness of the VW-51 implant.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-12-10; most recent amendment 2025-11-17.
Status change: Recruiting → Active, Not Recruiting 2025-11-17
Status change: Not Yet Recruiting → Recruiting 2023-12-21
Trial Details
NCT Number NCT06176170
Lead Sponsor VividWhite Pty Ltd
Conditions Glaucoma
Enrollment 65 participants
Start Date 2023-12-12
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-18